These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7787888)
21. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC. Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761 [TBL] [Abstract][Full Text] [Related]
22. DNA binding by N- and L-Myc proteins. Ma A; Moroy T; Collum R; Weintraub H; Alt FW; Blackwell TK Oncogene; 1993 Apr; 8(4):1093-8. PubMed ID: 8455937 [TBL] [Abstract][Full Text] [Related]
23. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction. Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821 [TBL] [Abstract][Full Text] [Related]
24. HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity. Wang YW; Chang HS; Lin CH; Yu WC Int J Biochem Cell Biol; 2007; 39(2):402-12. PubMed ID: 17070091 [TBL] [Abstract][Full Text] [Related]
25. c-myc activates RCC1 gene expression through E-box elements. Tsuneoka M; Nakano F; Ohgusu H; Mekada E Oncogene; 1997 May; 14(19):2301-11. PubMed ID: 9178906 [TBL] [Abstract][Full Text] [Related]
26. Interaction of the v-and c-Myb proteins with regulatory sequences of the human c-myc gene. Zobel A; Kalkbrenner F; Guehmann S; Nawrath M; Vorbrueggen G; Moelling K Oncogene; 1991 Aug; 6(8):1397-407. PubMed ID: 1679531 [TBL] [Abstract][Full Text] [Related]
27. Sequences flanking the E-box contribute to cooperative binding by c-Myc/Max heterodimers to adjacent binding sites. Walhout AJ; van der Vliet PC; Timmers HT Biochim Biophys Acta; 1998 Apr; 1397(2):189-201. PubMed ID: 9565685 [TBL] [Abstract][Full Text] [Related]
28. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Galang CK; Der CJ; Hauser CA Oncogene; 1994 Oct; 9(10):2913-21. PubMed ID: 8084596 [TBL] [Abstract][Full Text] [Related]
29. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts. Marcotte R; Chen JM; Huard S; Wang E J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342 [TBL] [Abstract][Full Text] [Related]
30. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc. Gupta K; Anand G; Yin X; Grove L; Prochownik EV Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857 [TBL] [Abstract][Full Text] [Related]
31. c-Myc induces the expression and activity of ornithine decarboxylase. Wagner AJ; Meyers C; Laimins LA; Hay N Cell Growth Differ; 1993 Nov; 4(11):879-83. PubMed ID: 8297793 [TBL] [Abstract][Full Text] [Related]
32. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively. Vervoorts J; Lüscher B Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451 [TBL] [Abstract][Full Text] [Related]
33. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element. Berberich SJ; Postel EH Oncogene; 1995 Jun; 10(12):2343-7. PubMed ID: 7784082 [TBL] [Abstract][Full Text] [Related]
34. Three distinct elements within the murine c-myc promoter are required for transcription. Moberg KH; Logan TJ; Tyndall WA; Hall DJ Oncogene; 1992 Mar; 7(3):411-21. PubMed ID: 1549358 [TBL] [Abstract][Full Text] [Related]
35. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding. McEwan IJ; Dahlman-Wright K; Ford J; Wright AP Biochemistry; 1996 Jul; 35(29):9584-93. PubMed ID: 8755740 [TBL] [Abstract][Full Text] [Related]
36. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2. Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135 [TBL] [Abstract][Full Text] [Related]
37. Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression. Iyengar RV; Pawlik CA; Krull EJ; Phelps DA; Burger RA; Harris LC; Potter PM; Danks MK Cancer Res; 2001 Apr; 61(7):3045-52. PubMed ID: 11306486 [TBL] [Abstract][Full Text] [Related]
38. Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex. Peña A; Reddy CD; Wu S; Hickok NJ; Reddy EP; Yumet G; Soprano DR; Soprano KJ J Biol Chem; 1993 Dec; 268(36):27277-85. PubMed ID: 8262968 [TBL] [Abstract][Full Text] [Related]
39. Identification of a PDGF-responsive element in the murine c-myc gene. Sacca R; Cochran BH Oncogene; 1990 Oct; 5(10):1499-505. PubMed ID: 2250909 [TBL] [Abstract][Full Text] [Related]
40. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Desbarats L; Gaubatz S; Eilers M Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]